The Impact of Targeted Estrogen Receptor (ER) Imaging on Breast Cancer Patients
October 19, 2022
Leading healthcare experts Dr. Hannah Linden and Dr. Gary Ulaner will offer their insights about a diagnostic imaging agent that may help inform physicians clinical decisions and treatment selection for people with recurrent or metastatic breast cancer.
Key takeaways from webinar viewers:
- FES PET scan better than FDG PET to diagnose metastatic diseases.
- Helpful tool to determine best treatment at the time of metastatic diagnosis or when there’s progression.
- More targeted scan will ensure more personalized care in hopes of longer survival.